/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Low-dose interleukin-2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY) / IVORY - Clinical Outcomes And Follow-up (IVORY FINALE) Study
Event: ESC Congress 2024
Topic: Pharmacotherapy
Session: Smaller trials, trial updates, and other studies on inflammation and immunity in cardiovascular disease
